PHIO
PHIO P/E Ratio
P/E Ratio as of Oct 29, 2026: -0.64
Average-0.6923
Median-0.6900
Minimum-0.7700
Maximum-0.6300
-0.64
0.13 (16.88%)past month
The P/E ratio for PHIO is -0.64 as of Oct 29, 2026. This represents a decrease of -3.03% compared to its 12-month average P/E ratio of -0.66. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Phio Pharmaceuticals Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Phio Pharmaceuticals Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Phio Pharmaceuticals Corp to industry peers.
Phio Pharmaceuticals Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Phio Pharmaceuticals Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Phio Pharmaceuticals Corp to industry peers.
PHIO P/E Ratio Insights
See Phio Pharmaceuticals Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PHIO
Order type
Buy in
Order amount
Est. shares
0 shares
PHIO P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $1.00 | -0.74 |
| Sep 1, 2026 | $1.10 | -0.82 |
| Aug 3, 2026 | $1.03 | -0.72 |
| Jul 1, 2026 | $1.00 | -0.70 |
| Jun 1, 2026 | $1.13 | -0.79 |
| May 1, 2026 | $1.14 | -0.76 |
| Apr 1, 2026 | $1.30 | -0.86 |
| Mar 2, 2026 | $1.02 | -0.46 |
| Feb 2, 2026 | $0.9871 | -0.44 |
| Jan 2, 2026 | $1.09 | -0.49 |
PHIO End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.64 | +36.17% |
| 2025 | -0.47 | +261.54% |
| 2024 | -0.13 | +44.44% |
| 2023 | -0.09 | -78.05% |
| 2022 | -0.41 | -56.84% |
| 2021 | -0.95 | — |
FAQs About Phio Pharmaceuticals Corp (PHIO) P/E ratio
The latest P/E ratio of PHIO is -0.64, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Phio Pharmaceuticals Corp’s last 12-month average P/E ratio is -0.66, compared to its current P/E ratio of -0.64. This reflects a decrease of -3.03%.
Phio Pharmaceuticals Corp’s current P/E ratio of -0.64 is lower than its last 12-month average P/E of -0.66. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Phio Pharmaceuticals Corp’s average P/E ratio over the last 3 years is -0.37. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Phio Pharmaceuticals Corp’s average P/E ratio over the last 5 years is -0.48. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
PHIO P/E Ratio Insights
See Phio Pharmaceuticals Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in PHIO
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.